Encouraging results from phase I trial of GVAX.
D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology; D011289:Preleukemia / Q000188:drug therapy* / Q000276:immunology; D014612:Vaccines / Q000276:immunology / Q000627:therapeutic use*
D014612:Vaccines